An algorithmic approach for the treatment of severe uncontrolled asthma

Eleftherios Zervas, Konstantinos Samitas, Andriana I. Papaioannou, Petros Bakakos, Stelios Loukides, Mina Gaga

Source: ERJ Open Res, 4 (1) 00125-2017; 10.1183/23120541.00125-2017
Journal Issue: January
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Eleftherios Zervas, Konstantinos Samitas, Andriana I. Papaioannou, Petros Bakakos, Stelios Loukides, Mina Gaga. An algorithmic approach for the treatment of severe uncontrolled asthma. ERJ Open Res, 4 (1) 00125-2017; 10.1183/23120541.00125-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Management of difficult-to-treat severe asthma
Source: Eur Respir Mon 2011; 51: 282-296
Year: 2011


Is it really severe asthma? A systematic approach to assessment
Source: International Congress 2019 – PG10 Severe asthma in adults: systematic assessment and biological treatment
Year: 2019


Bronchial thermoplasty: a new therapeutic option for the treatment of severe, uncontrolled asthma in adults
Source: Eur Respir Rev 2014; 23: 510-518
Year: 2014



Severe asthma: approach to diagnosis and treatment
Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond
Year: 2008



Non-drug methods in complex treatment of the severe bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 513s
Year: 2002

Two therapy option in patients with uncontrolled asthma
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018

The management of mild asthma
Source: Eur Respir J, 57 (4) 2003051; 10.1183/13993003.03051-2020
Year: 2021



Difficult-to-treat asthma : a multidimensional approach before considering targeted therapy
Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Year: 2019

The use of omalizumab in the management of severe chronic paediatric asthma
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008


Omalizumab is effective in patients with severe persistent allergic asthma in a real-life setting irrespective of age
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009


The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity
Source: Eur Respir J, 52 (5) 1800694; 10.1183/13993003.00694-2018
Year: 2018



Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma
Source: Annual Congress 2005 - Severe asthma: perception and management
Year: 2005


Improved definition of severe asthma phenotypes
Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop
Year: 2014




Distribution of biomarkers in severe asthma and severe uncontrolled asthma
Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research
Year: 2021



Ykl-40 and phenotyping of severe asthma
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019


Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017


Acute severe asthma: evidence-based management of asthma exacerbations
Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond
Year: 2008